Martin Daniel C. 4
4 · Deciphera Pharmaceuticals, Inc. · Filed Dec 1, 2023
Insider Transaction Report
Form 4
Martin Daniel C.
Chief Commercial Officer
Transactions
- Sale
Common Stock
2023-11-30$12.57/sh−17,801$223,755→ 45,435 total
Footnotes (2)
- [F1]Includes 352 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on November 14, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.56 to $12.625, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.